GAT-3 Dysfunction Generates Tonic Inhibition in External Globus Pallidus Neurons in Parkinsonian Rodents
Marine Chazalon,
Elena Paredes-Rodriguez,
Stéphanie Morin,
Audrey Martinez,
Sofia Cristóvão-Ferreira,
Sandra Vaz,
Ana Sebastiao,
Aude Panatier,
Eric Boué-Grabot,
Cristina Miguelez,
Jérôme Baufreton
Affiliations
Marine Chazalon
Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS UMR 5293, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France
Elena Paredes-Rodriguez
Department of Pharmacology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain
Stéphanie Morin
Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS UMR 5293, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France
Audrey Martinez
Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS UMR 5293, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France
Sofia Cristóvão-Ferreira
Institute of Pharmacology and Neurosciences, Faculty of Medicine, and Unit of Neuroscience, Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
Sandra Vaz
Institute of Pharmacology and Neurosciences, Faculty of Medicine, and Unit of Neuroscience, Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
Ana Sebastiao
Institute of Pharmacology and Neurosciences, Faculty of Medicine, and Unit of Neuroscience, Institute of Molecular Medicine, University of Lisbon, Lisbon, Portugal
Aude Panatier
INSERM U1215, Neurocentre Magendie, 33000 Bordeaux, France; Université de Bordeaux, 33000 Bordeaux, France
Eric Boué-Grabot
Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS UMR 5293, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France
Cristina Miguelez
Department of Pharmacology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain
Jérôme Baufreton
Université de Bordeaux, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; CNRS UMR 5293, Institut des Maladies Neurodégénératives, 33000 Bordeaux, France; Corresponding author
Summary: The external globus pallidus (GP) is a key GABAergic hub in the basal ganglia (BG) circuitry, a neuronal network involved in motor control. In Parkinson’s disease (PD), the rate and pattern of activity of GP neurons are profoundly altered and contribute to the motor symptoms of the disease. In rodent models of PD, the striato-pallidal pathway is hyperactive, and extracellular GABA concentrations are abnormally elevated in the GP, supporting the hypothesis of an alteration of neuronal and/or glial clearance of GABA. Here, we discovered the existence of persistent GABAergic tonic inhibition in GP neurons of dopamine-depleted (DD) rodent models. We showed that glial GAT-3 transporters are downregulated while neuronal GAT-1 function remains normal in DD rodents. Finally, we showed that blocking GAT-3 activity in vivo alters the motor coordination of control rodents, suggesting that GABAergic tonic inhibition in the GP contributes to the pathophysiology of PD. : The globus pallidus (GP) is a key basal ganglia nucleus involved in motor control. In Parkinson’s disease, the cellular mechanisms underlying GP neuron hypoactivity are poorly understood. Chazalon et al. find that glial GABA transporters are downregulated in parkinsonian rodents, leading to aberrant GABAergic inhibition in the GP and motor coordination impairment. Keywords: tonic inhibition, basal ganglia, extrasynaptic GABAA receptors, GABA transporters, electrophysiology